Follow Us
© 2026 Arizent. All rights reserved.
Tolbert is the founder and CEO of benefits administration platform & HR software company BerniePortal.
For reprint and licensing requests for this article, click here.
Industry leaders weigh the pros and cons of brokerage and advisory scale created through M&As vs. boutique shops.
While the legislation's future is still unclear, there are many important things for leaders to know.
As GLP-1 spending climbs, employers are asking whether the drugs deliver enough value. Better data could help them measure the payoff more accurately.
The legislation calls on Congress to lower prescription drug costs, shift subsidies directly to consumers, and enforce strict price transparency.
Employers are under pressure to keep benefits competitive while controlling costs, driving new scrutiny of PBMs, hospital prices and GLP-1 coverage for 2027.
